All news

Charles River lifts 2026 EPS guidance on tax reserve reversal

Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash

Charles River Laboratories raised its 2026 GAAP EPS guidance to US$8.15 to US$8.35, driven mainly by a third-quarter tax reserve reversal, even as top-line pressure persists. The company is leaning on operational efficiency and New Approach Methodologies such as Virtual Control Groups to offset softening demand in traditional research models.

Read original source

CRL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.